"Designing Growth Strategies is in our DNA"

U.S. Epinephrine Market Size, Share & COVID-19 Impact Analysis, By Product Type (Auto-injectors, Pre-filled Syringes, and Ampoules & Vials), By Application (Anaphylaxis, Cardiac Arrest, Respiratory Disorders, and Others), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108732

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, Key Players
    2. Pipeline Analysis, Key Players
    3. Pricing, Key Brands/ Key Players, 2022
    4. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
    5. Impact of COVID-19 on the Market
  5. U.S. Epinephrine Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Auto-injectors
      2. Pre-filled Syringes
      3. Ampoules & Vials
    2. Market Analysis, Insights and Forecast – By Application
      1. Anaphylaxis
      2. Cardiac Arrest
      3. Respiratory Disorders
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
        1. Viatris
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        2. Teva Pharmaceuticals
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        3. Adamis Pharmaceuticals Corporation
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        4. Kaleo, Inc.
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        5. Bausch Health Companies
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        6. Amneal Pharmaceuticals LLC.
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        7. ALK-Abelló A/S
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        8. BIOPROJET
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, Key Players
    2. Pipeline Analysis, Key Players
    3. Pricing, Key Brands/ Key Players, 2022
    4. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
    5. Impact of COVID-19 on the Market
  5. U.S. Epinephrine Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Auto-injectors
      2. Pre-filled Syringes
      3. Ampoules & Vials
    2. Market Analysis, Insights and Forecast – By Application
      1. Anaphylaxis
      2. Cardiac Arrest
      3. Respiratory Disorders
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
        1. Viatris
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        2. Teva Pharmaceuticals
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        3. Adamis Pharmaceuticals Corporation
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        4. Kaleo, Inc.
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        5. Bausch Health Companies
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        6. Amneal Pharmaceuticals LLC.
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        7. ALK-Abelló A/S
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
        8. BIOPROJET
          1. Overview
          2. Product
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
Read Less

Table 01: U.S. Epinephrine Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 02: U.S. Epinephrine Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 03: U.S. Epinephrine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Figure 01: U.S. Epinephrine Market Revenue Breakdown (USD billion, %) by Product Type, 2022 & 2030

Figure 02: U.S. Epinephrine Market Value Share (%), By Product Type, 2022 & 2030

Figure 03: U.S. Epinephrine Market Value Share (%), By Application, 2022 & 2030

Figure 04: U.S. Epinephrine Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 05: U.S. Epinephrine Market Share (%), 2022

U.S. Epinephrine Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports